DUBLIN--(BUSINESS WIRE)--The "Transfection Reagent And Equipment Market Size, Share, & Trends Analysis Report By Product, By Method, By Application (Gene Expression, Protein Production, Cancer Research, Therapeutics), And Segment Forecasts, 2014 - 2022" report has been added to ResearchAndMarkets.com's offering.
The global transfection reagent & equipment market size is expected to reach USD 1.08 billion by 2022, progressing at a CAGR of 7.4%.
The growth of the market can be attributed to ongoing oncology-based research & development that aimed at understanding disease cause at genomic & molecular levels coupled with consequent surging demand for targeted therapies.
Transfection technology is recognized as an integral part of research programs pertaining to thorough investigation of various chromosomal anomalies. Hence, rising cancer prevalence of cancer as well as genetic conditions is anticipated to provide a fillip to the market. Furthermore, funds and grants by funding and government bodies are likely to back the growth of the market.
Funding and federal agencies, such as National Science Foundation (NSF), are offering the biotechnology sector with huge funding to carry out their biotechnology-based investigational studies. Moreover, international funding bodies such as NIH and Welcome Trust are projected to play a crucial role in the growth of the market by providing funds for genetic research studies. Such significant funds and grants are poised to boost the adoption of transfection technology over the forecast period.
Thermo Fisher Scientific Inc., Promega Corporation, QIAGEN, and F.Hoffmann-La Roche Ltd are some prominent players in the market. These companies are undertaking several endeavors to enhance their shares in the market
Key Topics Covered:
Chapter 1 Executive Summary
Chapter 2 Research Methodology
Chapter 3 Transfection Reagents & Equipment Industry Outlook
Chapter 4 Transfection Reagents & Equipment Product Outlook
Chapter 5 Transfection Reagents & Equipment Method Outlook
Chapter 6 Transfection Reagents & Equipment Application Outlook
Chapter 7 Transfection Reagents & Equipment Regional Outlook
Chapter 8 Competitive Landscape
- Thermo Fisher Scientific Inc
- Promega Corporation
- Lonza AG
- Qiagen
- Mirus Bio LLC
- EMD Millipore
- Bio-Rad Laboratories Inc.
- OriGene Technologies Inc.
- Merck KgaA
For more information about this report visit https://www.researchandmarkets.com/research/2ckcgf/global?w=4
